Skip to main content
Clinical Trials/IRCT20190425043368N1
IRCT20190425043368N1
Recruiting
Phase 3

The evaluation of clinical and laboratory efficacy of four-hour infusion vs. half-hour infusion of Ampicillin-Sulbactam in empiric and definite treatment of patients with sepsis and severe sepsis in the intensive care unit of Namazee and shahid Rajaee hospital in Shiraz.

Shiraz University of Medical Sciences0 sites136 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: Severe Sepsis. Condition 2: Sepsis.
Sponsor
Shiraz University of Medical Sciences
Enrollment
136
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • More than 18 years old
  • Diagnosis of sepsis and severe sepsis based on qSOFA criteria
  • Taking Ampicillin\- Sulbactam at least for three days

Exclusion Criteria

  • Sensitivity to Ampicillin\- Sulbactam
  • Receiving Ampicillin\- Sulbactam more than 24 hours during 1 week before being admitted to the intensive care unit
  • Patients with GFR\<10 ml/min or hemodialysis
  • Patients with Pseudomonas, penicillin\-resistant staph aureus (MRSA), or stenotrophomonas

Outcomes

Primary Outcomes

Not specified

Similar Trials